基于人群队列的心肌病流行病学及新发心力衰竭研究
结果显示2010至2018年间所有心肌病患病率均上升,CA、DCM和RCM患者诊断时多已存在心衰,而ARVC和HCM患者更常在诊断后发生心衰,且心衰与心肌病诊断时间聚集。
要点
- 2010至2018年间所有心肌病患病率上升,ARVC增幅达180%,HCM增幅为9%。
- 诊断时CA、DCM和RCM患者多已存在心衰,而ARVC和HCM患者心衰多在诊断后发生。
- 心衰与心肌病诊断时间聚集,提示可更早识别或症状前诊断。
核心结论
- 过去十年所有心肌病患病率均上升。
- CA患者心衰常先于心肌病诊断,而ARVC或HCM患者更多在心肌病诊断后发生心衰,提示病程更缓慢或无症状识别更好。
- 心衰与心肌病诊断时间聚集,为症状前或更早诊断提供机会。
研究设计与样本
- 将心肌病分为肥厚型心肌病(HCM)、扩张型心肌病(DCM)、致心律失常性右室心肌病(ARVC)、限制型心肌病(RCM)和心脏淀粉样变(CA)。
主要发现
- 2018年DCM是最常见的心肌病。
- DCM和HCM在男性中患病率为两倍,ARVC则呈相反趋势。
- 2010至2018年间,ARVC患病率增加180%,HCM增加9%。
- 诊断时CA(66%)、DCM(56%)和RCM(62%)患者存在既存心衰的比例高于ARVC(29%)和HCM(27%)。
- 在诊断心肌病时无心衰的患者中,CA和DCM的年化心衰发病率最高。
临床怎么用
- 对CA、DCM和RCM患者应评估并管理既存心衰。
- 对ARVC和HCM患者需长期监测心衰发生。
- 心衰与心肌病诊断时间聚集提示可对高危人群更早筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The population prevalence of cardiomyopathies and the natural history of symptomatic heart failure (HF) and arrhythmia across cardiomyopathy phenotypes is poorly understood. Study aims were to estimate the population-diagnosed prevalence of cardiomyopathies and describe the temporal relationship between a diagnosis of cardiomyopathy with HF and arrhythmia. METHODS: People with cardiomyopathy (n=4116) were identified from linked electronic health records (~9 million individuals; 2000-2018) and categorised into hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), restrictive cardiomyopathy (RCM) and cardiac amyloidosis (CA). Cardiomyopathy point prevalence, rates of symptomatic HF and arrhythmia and timing relative to a diagnosis of cardiomyopathy were determined. RESULTS: In 2018, DCM was the most common cardiomyopathy. DCM and HCM were twice as common among men, with the reverse trend for ARVC. Between 2010 and 2018, prevalence increased for ARVC by 180% and HCM by 9%. At diagnosis, more patients with CA (66%), DCM (56%) and RCM (62%) had pre-existing HF compared with ARVC (29%) and HCM (27%). Among those free of HF at diagnosis of cardiomyopathy, annualised HF incidence was greatest in CA and DCM. Diagnoses of all cardiomyopathies clustered around the time of HF onset. CONCLUSIONS: The recorded prevalence of all cardiomyopathies increased over the past decade. Recognition of CA is generally preceded by HF, whereas individuals with ARVC or HCM more often developed HF after their cardiomyopathy diagnosis suggesting a more indolent course or better asymptomatic recognition. The clustering of HF and cardiomyopathy diagnoses suggests opportunities for presymptomatic or earlier diagnosis.
引用
- Brownrigg, Leo, Rose, et al. Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study. Heart. 2022. PMID: 34969871. doi:10.1136/heartjnl-2021-320181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。